Skip to main content

1 Result(s)

within Chiyoon Oum Remove this filter

and

  1. Article

    Open Access

    Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis

    While immunotherapy combined with chemotherapy (Chemo-IO) is generally recognized for providing superior outcomes compared to monotherapy (mono-IO), it is associated with a higher incidence of treatment-relate...

    Sangwon Shin, Jimin Moon, Chiyoon Oum, Seulki Kim, Soo Ick Cho, Yoojoo Lim… in BMC Cancer (2024)

    Download PDF (1475 KB) View Article